The initial weeks of GLP-1 therapy represent an adjustment period as your body adapts to the medication
Even though its one of the older members of the family, Saxenda's role in the GLP-1 receptor agonist family is not to be underestimated, as it offers an alternative for patients who may not be suitable candidates for Ozempic or Wegovy
For now, there are no data on the efficacy of these therapeutics in the treatment of DN
This is the rationale for FINE-ONE attempting to translate a well-established T2D paradigm into the long-neglected space of DKD in patients with type 1 diabetes
Muscle plays a key part in glucose regulation and can help reduce insulin resistance, both of which are especially relevant for those of us with PCOS
However, those with Medicare, Medicaid, and Tricare are not eligible for GLP-1s through LifeMD, due to coverage limitations for these medications